Viewing Study NCT04533451


Ignite Creation Date: 2025-12-24 @ 11:50 PM
Ignite Modification Date: 2025-12-25 @ 9:44 PM
Study NCT ID: NCT04533451
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-06-13
First Post: 2020-08-19
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Testing the Effects of MK-3475 (Pembrolizumab) With or Without the Usual Chemotherapy Treatment for Patients 70 Years of Age and Older With Advanced Non-small Cell Lung Cancer
Sponsor: Alliance for Clinical Trials in Oncology
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2020-11-16
Start Date Type: ACTUAL
Primary Completion Date: 2023-10-31
Primary Completion Date Type: ACTUAL
Completion Date: 2027-05-31
Completion Date Type: ESTIMATED
First Submit Date: 2020-08-19
First Submit QC Date: None
Study First Post Date: 2020-08-31
Study First Post Date Type: ACTUAL
Results First Submit Date: 2024-10-21
Results First Submit QC Date: None
Results First Post Date: 2025-01-27
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-06-04
Last Update Post Date: 2025-06-13
Last Update Post Date Type: ACTUAL